about
Signaling in Effector Lymphocytes: Insights toward Safer ImmunotherapyP53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic LeukemiaCD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.Chimeric antigen receptor-redirected T cells return to the benchAdoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen ReceptorsNovel Therapeutic Strategies in Acute Lymphoblastic Leukemia.Chimeric antigen receptors: driving immunology towards synthetic biology.RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope.Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.Clinical trials of CAR-T cells in ChinaOptimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies.Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.Genetically enhanced T lymphocytes and the intensive care unit.Cytokine release syndrome: grading, modeling, and new therapy
P2860
Q26744654-E7E291FA-6B01-4B90-8FB3-60A3102BAB35Q28078609-4215EDB3-5E65-4FF1-B54F-05511EC1E611Q37058098-3E0C5062-E77B-4BC9-92E3-A8894FDA2FDCQ37301510-834B09BD-0D73-4A33-926C-FF159EFC7A7AQ38603686-AA6D0CA1-5972-4226-AE06-BAB2094EB222Q38813978-575188FC-AE0F-435D-B4BC-8E995B5C847CQ38884383-8D56A737-DC3B-4324-8E65-FE3C39C92400Q40736714-55179511-B9C8-4A94-8DB8-5CA43A8358BEQ41843869-0C96E70D-D47A-44F7-B48D-FBD2D7CF79F3Q42654456-17026A34-3137-4807-9D81-4E57E0BD7E04Q47565868-6DE87081-7CED-4E1E-801C-4EAEAE0FCD58Q55193924-DA50B49B-7A86-41C3-A641-93A140EED10FQ55312558-17DE5722-E4BD-4A83-BA46-44C80111B241Q55380614-A8FFFB62-93AD-4477-AD1E-C4BDD80B2A70Q58700983-BE606845-5E74-4C4F-B2B9-761A97114E0A
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@ast
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@en
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@nl
type
label
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@ast
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@en
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@nl
prefLabel
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@ast
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@en
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@nl
P2093
P3181
P1476
CD19 CAR Therapy for Acute Lymphoblastic Leukemia
@en
P2093
Isabelle Rivière
Michel Sadelain
Renier Brentjens
P304
P3181
P356
10.14694/EDBOOK_AM.2015.35.E360
P407
P577
2015-01-01T00:00:00Z